Nova Organic Public Company Limited

SET:NV.BK

1.12 (THB) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) THB.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 141.704137.76144.368140.922158.041169.83186.539143.78212.197211.249326.524267.81294.925405.201961.936651.902420.268197.183
Cost of Revenue 81.80580.8489.86783.96589.95892.74295.06196.639110.558106.782119.902128.777103.092114.649233.188154.608108.43975.352
Gross Profit 59.89956.9254.50156.95768.08377.08891.47847.141101.639104.467206.622139.033191.833290.552728.748497.294311.829121.831
Gross Profit Ratio 0.4230.4130.3780.4040.4310.4540.490.3280.4790.4950.6330.5190.650.7170.7580.7630.7420.618
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 22.03620.97845.97522.32121.97823.72525.03218.62322.67721.06323.09822.42621.04229.95428.36122.82716.48914.509
Selling & Marketing Expenses 59.3655.84811.00860.24163.83254.09794.56258.282111.02586.841183.834101.911180.286187.561322.514152.06290.62234.726
SG&A 81.39676.82675.46782.56285.8177.822119.59476.905133.702107.904206.931124.337201.328217.515350.874174.889107.11149.235
Other Expenses -0.5620000-4.4731.412-0.3730.5450.4940.4730.270.3241.2540.1570.10.2170.58
Operating Expenses 81.39676.82675.46782.03185.20473.349121.00676.532133.702107.904206.931124.337200.831216.697352.566174.755107.11149.08
Operating Income -21.497-19.906-20.966-25.074-17.1214.556-29.529-29.391-32.063-2.5950.16314.966-9.17174.291385.672322.505204.93573.346
Operating Income Ratio -0.152-0.144-0.145-0.178-0.1080.027-0.158-0.204-0.151-0.0120.0010.056-0.0310.1830.4010.4950.4880.372
Total Other Income Expenses Net -0.4972.618-6.5311.9081.0990.4193.961.4750.9850.1470.5150.266-0.7759.2246.2380.11.5240.58
Income Before Tax -21.994-17.288-27.497-22.627-14.9614.975-25.569-27.916-31.078-2.4480.06814.823-9.52482.51382.256322.659206.3473.29
Income Before Tax Ratio -0.155-0.125-0.19-0.161-0.0950.029-0.137-0.194-0.146-0.01200.055-0.0320.2040.3970.4950.4910.372
Income Tax Expense 6.5060.6546.112-0.7770.4982.151.002-2.896-0.706-0.231-6.0611.816-1.54913.32481.08965.5442.11814.989
Net Income -28.5-17.942-33.605-21.74-15.3052.846-26.571-25.02-30.372-2.2176.12913.007-7.97569.186301.167257.119164.22258.301
Net Income Ratio -0.201-0.13-0.233-0.154-0.0970.017-0.142-0.174-0.143-0.010.0190.049-0.0270.1710.3130.3940.3910.296
EPS -0.05-0.031-0.057-0.038-0.0260.005-0.044-0.042-0.051-0.0040.010.022-0.0130.120.50.430.270.097
EPS Diluted -0.05-0.031-0.057-0.038-0.0260.005-0.044-0.042-0.051-0.0040.010.022-0.0130.120.50.430.270.097
EBITDA -10.712-9.196-11.649-15.461-8.02511.509-19.408-21.45-23.8793.444.45520.398-4.53179.912380.795325.513207.05775.427
EBITDA Ratio -0.076-0.067-0.081-0.11-0.0510.068-0.104-0.149-0.1130.0160.0140.076-0.0150.1970.3960.4990.4930.383